ProfileGDS5822 / ILMN_2651350
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 37% 15% 2% 50% 31% 44% 5% 2% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 117.437
GSM1276600PDAC Late Ablation Control 213.315
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 15.12
GSM1276603PDAC Late Ablation 22350
GSM1276604PDAC Late Ablation 31631
GSM1303940PDAC Late Ablation_anti-CTLA4 119.944
GSM1303941PDAC Late Ablation_anti-CTLA4 24.45
GSM1303942PDAC Late Ablation_anti-CTLA4 32.12